133
Views
51
CrossRef citations to date
0
Altmetric
Review

Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses

, &
Pages 1633-1644 | Published online: 07 Sep 2015

References

  • AshworthJLBiswasSWraithELloydICMucopolysaccharidoses and the eyeSurv Ophthalmol200651111716414358
  • ClarkeLAPathogenesis of skeletal and connective tissue involvement in the mucopolysaccharidoses: glycosaminoglycan storage is merely the instigatorRheumatology (Oxford)201150Suppl 5v13v1822210665
  • KumarVAbbasAKFaustoNAsterJCRobbins and Cotran Pathologic Basis of Disease8th edPhiladelphiaSaunders2010
  • CimazRLa TorreFMucopolysaccharidosesCurr Rheumatol Rep20141638924264718
  • ZiyadehJLe MerrerMRobertMArnaudEValayannapoulosVDi RoccoFMucopolysaccharidosis type I and craniosynostosisActa Neurochir (Wien)20131551973197623917744
  • GoldaAJureckaATylki-SzymanskaACardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)Int J Cardiol201215861121737154
  • AlroyJHaskinsMBirkDEAltered corneal stromal matrix organization is associated with mucopolysaccharidosis I, III and VIExp Eye Res19996852353010328965
  • MollardRJTeleganPHaskinsMAguirreGCorneal endothelium in mucopolysaccharide storage disorders. Morphologic studies in animal modelsCornea199615125348907377
  • HuangYBronAJMeekKMVellodiAMcDonaldBUltrastructural study of the cornea in a bone marrow-transplanted Hurler syndrome patientExp Eye Res1996623773878795456
  • CollinsMLTraboulsiElMaumeneeIHOptic nerve head swelling and optic atrophy in the systemic mucopolysaccharidosesOphthalmology19909711144514492123975
  • SchumacherRGBrzezinskaRSchulze-FrenkingGPitzSSonographic ocular findings in patients with mucopolysaccharidoses I, II and VIPediatr Radiol20083854355018299822
  • NowaczykMJClarkeJTMorinJDGlaucoma as an early complication of Hurler’s diseaseArch Dis Child198863109110933140740
  • GaneshABruwerZAl-ThihliKAn update on ocular involvement in mucopolysaccharidosesCurr Opin Ophthalmol201324537938823872816
  • FahnehjelmKTAshworthJLPitzSClinical guidelines for diagnosing and managing ocular manifestations in children with mucopolysaccharidosisActa Ophthalmol20129059560222136369
  • FahnehjelmKTChenEWiniarskiJCorneal hysteresis in mucopolysaccharidosis I and VIActa Ophthalmol2012544544821232085
  • “Mucopolysaccharidoses Fact Sheet”National Institute of Neurological Disorders and Stroke (NINDS) [webpage on the Internet] Available from www.ninds.nih.gov/disorders/mucopolysaccharidoses/detail_mucopolysaccharidoses.htmAccessed September 1, 2014
  • AragonaPWylegalaEWroblewska-CzajkaEClinical, confocal, and morphological investigations on the cornea in human mucopolysaccharidosis IH-SCornea2014331354224212765
  • ScarpaMMucopolysaccharidosis type IIPagonRAAdamMPArdingerHHGeneReviews® [Internet]Seattle, WAUniversity of Washington19932015 Available from: www.ncbi.nlm.nih.gov/books/NBK1116/Accessed November 16, 2014
  • WraithJEMucopolysaccharidoses and oligosaccharidosesSaudubrayJMvan den BergheGWalterJHInborn Metabolic Diseases: Diagnosis and Treatment5th edNew York, NYSpringer201239497507
  • Käsmann-KellnerBWeindlerJPfauBRuprechtKWOcular changes in mucopolysaccharidosis IV A (Morquio A syndrome) and long-term results of perforating keratoplastyOphthalmologica1999213320020510202296
  • NatowiczMRShortMPWangYClinical and biochemical manifestations of hyaluronidase deficiencyN Engl J Med1996335102910338793927
  • ImundoLLeducCAGuhaSA complete deficiency of Hyaluronoglucosaminidase 1 (HYAL1) presenting as familial juvenile idiopathic arthritisJ Inherit Metab Dis2011341013102221559944
  • SummersCGFahnehjelmKTPitzSSystemic therapies for mucopolysaccharidosis: ocular changes following haematopoietic stem cell transplantation or enzyme replacement therapy – a reviewClin Experiment Ophthalmol2010383442
  • PitzSOgunOBajboujMArashLSchulze-FrenkingGBeckMOcular changes in patients with mucopolysaccharidosis I receiving enzyme replacement therapy: a 4-year experienceArch Ophthalmol2007125101353135617923542
  • FerrariSPonzinDAshworthJLDiagnosis and management of ophthalmological features in patients with mucopolysaccharidosisBr J Ophthalmol20119561361920852315
  • ElfleinHMHofherrTBerisha-RamadaniFMeasuring corneal clouding in patients suffering from mucopolysaccharidosis with the Pentacam densitometry programmeBr J Ophthalmol201397782983323685998
  • AslamTMShakirSWongJAuLAshworthJUse of iris recognition camera technology for the quantification of corneal opacification in mucopolysaccharidosesBr J Ophthalmol201296121466146822394489
  • BothunEDDecaniniASummersCGOrchardPJTolarJOutcome of penetrating keratoplasty for mucopolysaccharidosesArch Ophthalmol2011129213814421320956
  • KottlerUDemirDSchmidtmannIBeckMPitzSCentral corneal thickness in mucopolysaccharidosis II and VICornea201029326026220098308
  • MullaneyPAwadAHMillarLGlaucoma in mucopolysaccharidosis 1–H/SJ Pediatr Ophthalmol Strabismus19963321271318965238
  • ChristiansenSPSmithTJHenslee-DowneyPJNormal intraocular pressure after a bone marrow transplant in glaucoma associated with mucopolysaccharidosis type I-HAm J Ophthalmol199010922302312105651
  • GullingsrudEOKrivitWSummersCGOcular abnormalities in the mucopolysaccharidoses after bone marrow transplantation. Longer follow-upOphthalmology19981056109911059627663
  • ConnellPMcCreeryKDoyleADarcyFO’MearaABrosnahanDCentral corneal thickness and its relationship to intraocular pressure in mucopolysaccararidoses-1 following bone marrow transplantationJ AAPOS200812171017588792
  • KoseogluSTHarmatzPTurbevilleSNicelyHReversed papilledema in an MPS VI patient with galsulfase (Naglazyme) therapyInt Ophthalmol200929426726918418554
  • PitzSOgunOArashLMiebachEBeckMDoes enzyme replacement therapy influence the ocular changes in type VI mucopolysaccharidosis?Graefes Arch Clin Exp Ophthalmol2009247797598019159944
  • TzetziDHamiltonRRobinsonPHDuttonGNNegative ERGs in mucopolysaccharidoses (MPS) Hurler-Scheie (I-H/S) and Hurler (I-H)-syndromesDoc Ophthalmol200711415315817464575
  • VerdugoMEScarpinoVMoullierPHaskinsMEAguirreGDRayJAdenoviral vector-mediated beta-glucuronidase cDNA transfer to treat MPS VII RPE in vitroCurr Eye Res200123535736711910525
  • FahnehjelmKTTörnquistALWiniarskiJOcular axial length and corneal refraction in children with mucopolysaccharidosis (MPS I-Hurler)Acta Ophthalmol20129028729020553232
  • The medical biochemistry page [website on the Internet] [updated May 14, 2015]. Available from: http://themedicalbiochemistrypage.org/Accessed May 9, 2015